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Abstract 
In this study, we explored the utility of a descriptive and predictive bionetwork model 
for phospholipase C-coupled calcium signaling pathways, built with non-kinetic experimental 
information. Boolean models generated from these data yield oscillatory activity patterns for 
both the endoplasmic reticulum resident inositol-1,4,5-trisphosphate receptor (IP3R)  and the 
plasma-membrane resident canonical transient receptor potential channel 3 (TRPC3).  These 
results are specific as randomization of the Boolean operators ablates oscillatory pattern 
formation.  Furthermore, knock-out simulations of the IP3R, TRPC3, and multiple other 
proteins recapitulate experimentally derived results.   The potential of this approach can be 
observed by its ability to predict previously undescribed cellular phenotypes using in vitro 
experimental data.  Indeed our cellular analysis of the developmental and calcium-regulatory 
protein, DANGER1a, confirms the counter-intuitive predictions from our Boolean models in 
two highly relevant cellular models.  Based on these results, we theorize that with sufficient 
legacy knowledge and/or computational biology predictions, Boolean networks provide a 
robust method for predictive-modeling of any biological system. 
 
Introduction  
 Calcium signaling networks are comprised of multiple nodes including: (i) receptors and 
ligands, (ii) soluble second messengers, and (iii) selective/non-selective ion-channels.  Within these 
signal transduction pathways, ligand-binding to either a G-protein coupled receptor (GPCR) or 
tyrosine-kinase receptor (RTK) in the plasma-membrane initiates numerous short-term and long-term 
cellular signals.  These signals initiate cellular programs responsible for growth, development, 
secretion, and apoptosis [1;2].  Subsequent to ligand binding, GPCRs activate the heterotrimeric G-
protein complex (Gα and Gβγ) which stimulates phospholipase C-beta (PLCβ) mediated catalysis of 
phosphatidylinositol (4,5) bisphosphate (PIP2) to the second messengers inositol-1,4,5-trisphosphate 
(IP3) and diacylglycerol (DAG).  Similarly, ligand activation of RTKs results in the direct activation of 
phospholipase C-gamma (PLCγ), and its catalysis of PIP2.  In this way, IP3 is generated and activates 
inositol-1,4,5-trisphosphate receptors (IP3R), a large conductance Ca2+ channel on membranes of 
Ca2+ containing stores.  Active IP3R releases Ca2+ into the cytosol, as well as other cellular 
compartments (e.g. nucleus, mitochondria, etc)[1;3].  Recent studies also demonstrate that IP3Rs are 
regulated by a large suite of proteins which can both positively and negatively influence their calcium 
conductance.  Further, IP3R is also integral to Ca2+ entry mechanisms [1;4], and is a known regulator 
of transient receptor potential channels (TRPs), a superfamily of ion-channels involved in sensory 
perception [4;5].   
 
 The output of these signals provides Ca2+ oscillations/waves which spatially regulate protein 
function to accomplish diverse physiological/pathophysiological processes, such as sensory 
perception [6], cell development and growth[7;8], hearing[9;10], taste[11], and fertility[12] as well as 
multiple diseases including mucolipodosis [13;14] and polycystic kidney disease[4;13;15]. Although 
our understanding of many of the core components is well-developed for certain steps within IP3R 
containing Ca2+ networks, our understanding of how these signals are integrated with temporal and 
spatial precision is severely lacking.   
 
 The Ca2+ signaling network, even within a single cell, may contain hundreds if not thousands of 
different nodes (proteins, small molecules, lipids, ions, etc).  Pioneers of network analyses have 
attempted to model Ca2+ signaling networks using kinetic data from biochemical experimentation [16-
20].  One such study by Bhalla and Iyengar [21] demonstrated that by building a library of small 
signaling network modules (e.g. PLC, MAP kinase, PKC, PLA2, etc), they could build a network which 
could simulate multiple functional outputs such as intracellular Ca2+ concentration, kinase activity, 
phosphatase activity, etc.  Further, a number of non-intuitive results were derived that could be 
recapitulated in the laboratory [21].  Kinetic models built from experimental data can also successfully 
predict the effects of protein knock-down on cellular Ca2+ dynamics [18].  Maurya and Subramaniam 
demonstrated that protein knock-down does not have a linear correlation to loss of function (e.g. 18% 
knock-down of Gβγ equals a 50% loss of activity, which is also equivalent to a 60% knock-down of 
receptor protein)[17;18]. Taken together, these results highlight the utility of kinetic network modeling. 
 
 Network analyses using quantitative kinetic data are powerful and predictive[17;18;22;23]; 
however, the differential equations required to process these types of data require detailed 
information and enormous computational power. Furthermore, kinetic data for individual steps in the 
network is often lacking.  Thus, generating larger scale network simulations is sometimes not 
feasible.  Discrete network modeling (e.g. Boolean) may provide a solution to this problem, as it was 
demonstrated that in many networks kinetic parameters are not essential in describing the overall 
dynamics [24;25].  Moreover, Boolean models characterize nodes with two qualitative states and only 
use three operators (AND, OR, NOT); thus, significantly reducing the computational power needed to 
run Boolean simulations as compared to kinetic network models [26;27].   
 
 In the present study, we investigate whether Boolean modeling can be used to study PLC-
coupled Ca2+ signaling pathways.  Our results demonstrate that (i) Ca2+ networks can be constructed 
from legacy knowledge, (ii) experimental data from these multiple sources can be used to define 
network directionality and Boolean update rules for each node in network, and (iii) network modeling 
based on these Boolean rules provide a descriptive and predictive model of PLC-mediated Ca2+ 
signaling.  In addition, we experimentally validate a previously uncharacterized node (DANGER1a) in 
the network simulations.  Taken together, we suggest that Boolean modeling provide an effective 
method for creating receptor specific and/or cell-specific signaling network models.   
 
Results  
Constructing the Bionetwork and Generating Boolean Rules   
We chose to build a model for PLC-coupled Ca2+ signaling pathways due to the significant 
literature base for this receptor [28].  Nodes within the network were chosen based on two criteria: (1) 
they have known 
activity(s) within these 
pathways and (2) they are 
known to have causal 
interactions, and not just 
associative interactions 
with other nodes in the 
network (see Methods for 
a complete description).  
Figure 1 depicts the 
bionetwork generated 
using this scheme.  
Although this is a subset 
of the known 
nodes/integrators for 
phospholipase C-
mediated signaling, 
bionetworks are often 
resilient, even in the 
absence of a significant 
number of nodes [29].  In 
addition, nodes were 
chosen that have, in 
general, considerable 
experimental support[1;3].  
Furthermore, as all 
GPCRs and RTKs flow 
through either PLCβ or 
PLCγ, our network results 
Figure 1: Bionetwork of Serotonin Induced Calcium Signaling Pathway
Calcium channels have been shown in green color, calcium release and entry are blue, and all 
other signaling components have been shown in yellow.  Solid arrows represent positive interaction 
between nodes, and dashed arrows represent inhibition. ‘*’ denotes hydrolysis of 
phosphatidylinositol bisphosphate. Full names of abbreviations used in the network are: 5-HTR, 5-
hydroxytryptamine receptor; PLCβ/γ ,  Phospholipase C Beta/Gamma; PIP2, phosphatidylinositol
bisphosphate; DAG, Diacylglycerol; IP3, Inositol trisphosphate; PKA, Protein Kinase A; PKC, 
Protein kinase C; SERCA, Sarco/Endoplasmic Reticulum Ca2+-ATPase; IP3R, Inositol 1,4,5-
Trisphosphate Receptor; TRPC3, Transient receptor potential cation channel, subfamily C, 
member 3; CaBP1, Calcium Binding Protein1;ATPcyt , cytoplasmic ATP in vicinity to IP3R 
channels; CAM, Calmodulin; CamkII, Ca2+/calmodulin-dependent protein kinase II
should be applicable to numerous receptor types (e.g. muscarinic, serotonergic, B-cell receptors, etc).  
From this topology, we observe that the IP3R and the canonical TRP channel 3 (TRPC3) form hubs 
(highly-connected nodes) within the network.  This implies that these channels are highly regulated, 
which is reasonable as both of these proteins flux the signaling ion, Ca2+. 
  
After constructing the network, we defined our Boolean rules for updating each node in terms of logic 
operators (AND, OR, NOT) (Figure 2).  In this method, nodes can have only two states, ON or OFF 
(see Table 1). ON can 
represent states such as 
ACTIVE (e.g. kinases, 
phosphatases, lipases 
etc.), OPEN (e.g. 
channels) and/or 
BINDING (e.g protein-
protein or protein-lipid 
interactions). Conversely, 
OFF can represent 
INACTIVE, CLOSED 
and/or NON-BINDING 
states.  
 
 
 
To define the Boolean 
update rules for each 
node, directionality 
information between 
nodes, as provided by 
legacy knowledge, is 
converted to logical 
operator driven 
statements. Thus, the 
future state of each node 
is dependent upon the 
present state of its 
interacting nodes. We 
created these logic 
operators for all nodes in 
the network using either 
legacy knowledge or our 
own experimental data  in 
defining rules (see Table 
1  for rules used).  For 
example, we used our 
own experimental results 
to define update rules for 
Figure 2: Flowchart of Bionetwork-Boolean Modeling Workflow
Bionetwork is developed based on current knowledge and rules for updating each node defined in 
form of logical operators (AND/OR/NOT). For synchronous modeling, each node is updated at 
each time step. For asynchronous modeling, random numbers of nodes are updated at each time 
step. Boolean states of each node in each time step is noted down in each update method and 
analyzed for attracting behavior. (see Methods for details)
Table 1: Boolean Rules for updating each node in network 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Node Boolean Regulatory Rule  
HTR HTR* = serotonin 
PLCβ PLCβ* = HTR 
cAMP cAMP* = HTR 
DAG DAG* = PIP2 and (PLCβ or PLCγ) 
PLCγ PLCγ* = HTR 
IP3 IP3* = PIP2 and (PLCβ or PLCγ) 
PKC PKC* = {DAG and (Ca2+ or Ca2+ER(Low) or Ca2+ER(High))} 
TRPC3 TRPC3* = {(not HOMER) and (IP3RLow and PLCγ and CAM)} or 
(DAG and not PKC) 
HOMER HOMER* = not IP3RLow 
Ca2+ER(High) Ca2+*ER(High) = IP3RHigh  
CAM CAM* = (Ca2+ or Ca2+ER(Low) or Ca2+ER(High)) 
SERCA SERCA* = (Ca2+ or Ca2+ER(Low) or Ca2+ER(High)) 
CaBP1 CaBP1* = Ca2+ER(High)  and DANGER 
ATPcyt ATP*cyt = not SERCA 
CamKII CamKII* =CAM 
IP3RLow IP3R*Low = {(IP3 and DANGER and (PKC or PKA or CamKII or Gβ3)} 
and not (IRBIT or CaBP1 or ATPcyt) 
IP3RHigh IP3R*High = {(IP3 and DANGER and PKC and PKA and Gβ3)} and not 
(IRBIT or CaBP1 or ATPcyt) 
DANGER DANGER* = HTR   
Gβ3 Gβ3* = HTR 
IRBIT IRBIT* = CamkII 
Ca2+ Ca2+* = TRPC3 
 
Heterotrimeric G-protein β3 (Gβ3). Studies from Zeng et al. [30] demonstrate that heterotrimeric G-
proteins have the ability to stimulate IP3R activity directly, although direct binding has not been 
determined.  We tested the hypothesis that Gβ3 and IP3R bind directly.  Yeast two-hybrid analysis 
reveals that the third and fourth WD40 repeats of Gβ3 are critical for binding (Figure 3a). We next 
examined the direct binding of the IP3R to full-length Gβ3 or a mutant Gβ3 containing deletions in the 
third and fourth WD40 repeats (aa166–207) (Figure 3b). Whereas full-length Gβ3 binds to IP3R, 
binding is abolished by deletion of the two WD40 repeats.  
 
To explore an influence of Gβ3 on 
IP3R function, we first evaluated 
the influences of 50 nM Gβ3 on 
[3H]IP3 binding to IP3R in rat brain 
membranes (Figure 3c). Gβ3 
increases the potency of 
unlabeled IP3 in competing for 
[3H]IP3 binding ≈3 fold. We next 
evaluated the influence of 50 nM 
Gβ3 on IP3-induced Ca2+ release 
from microsomal membrane 
preparations of COS7 cells 
(Figure 3d). We do not observe 
activation of IP3R by Gβ3 alone, 
even with high concentration of 
Gβ3 (10 μM) (data not shown). 
These observations suggest that 
Gβ3 acts by enhancing the affinity 
of IP3 for IP3R rather than by 
altering the channel itself, which 
would lead to a greater maximal 
release.  Taken together, the 
activity results are in accord with 
Zeng et al. although we do not 
observe direct activation of the 
IP3R by Gβ3 in the absence of 
IP3.   
 
Further, we  generated primary B-
cell lines from human patients 
which were either WT or 
homozygous for the C825T 
polymorphism [31].  This is a 
naturally occurring polymorphism 
which results in a frameshift 
mutation leading to the deletion of 
amino acids 166-207 in Gβ3.  In 
these cells we measured Ca2+ 
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Figure 3: Gβ3 binds and regulates IP3R activity (a) Yeast two-hybrid analysis 
shows that Gβ3 binds to IP3R through its 3rd and 4th WD repeats (aa 166-207). 
Fragments of Gβ3 lacking in region 166-207 do not show any binding (b) Pull 
down experiments in HEK293 lysates with GST tagged full length and mutated 
Gβ3 (Δ166-207) were performed. Full length Gβ3 shows a direct binding to IP3R 
while there is no binding between mutant Gβ3 and IP3R. (c) In [3H]IP3 treated Rat 
brain membranes, Gβ3 (50nM) increased IP3 binding to IP3R. (d) In microsomal
membrane of COS7 cells, Gβ3 (50 nM) leads to maximum calcium release at 30 
nM IP3. (e) Quantification of Ca2+ mobilization in human B cells lines from either 
Wild Type (WT) or C825T homozygous mutants stimulated with 10 mM anti-
human IgM. Area under individual calcium traces was measured and it shows that 
there is no statistical difference in Ca2+ release between WT and C825T mutants 
(Area under the curve, n= average 396 cells from 16 replicates across 4 different 
cell lines for WT and n=average 220 cells from 10 replicates across 3 different cell 
lines for C825T mutants, Error Bars: Std. Dev.) 
release in response to B-cell receptor stimulation with anti-IgM which stimulates the RTK B-cell 
receptor[32-34].  The area under the curve from these measurements were quantified from numerous 
replicates and compared (see Methods for complete description).   Although we do observe that 
some of these preparations have alterations in Ca2+ signaling, our results from multiple genetic 
backgrounds provided no statistical difference between WT and mutant preparations (Figure 3e). 
 
Based on these experimental findings we defined the Boolean rule for the Gβ3 node (Figure 1 
and Table 1).  Specifically, in our rules Gβ3 enhances the activity of the IP3R although it is non-
essential. Indeed, the IP3R is expressed in all cells[1;35-37]  whereas Gβ3 is not [38].   
 
Synchronous and Asynchronous Simulations of the Serotonin Bionetwork 
Following, we performed two types of Boolean modeling.  Synchronous Boolean modeling 
assumes that the time required for each biological reaction is comparable and thus a unit time-step 
can be defined (Figure 2).  Therefore, when performing synchronous modeling we simultaneously 
update all node states according to the rules (Table 1) at each time-step.  Conversely, asynchronous 
Boolean modeling assumes that each biological reaction has distinct durations. Since there is not 
enough quantitative information available to estimate the reaction durations, we randomly shuffle the 
order of nodes at each time-step (Figure 2). Thus, this approach samples differential time intervals for 
each biological reaction in network. The results from these simulations were assayed for their 
attracting behavior (i.e. repetitive behavior).  
 
Results from our 
simulations can be plotted 
as a function of the 
Boolean state versus the 
time-step.  Figure 4A 
depicts the behavior for 
the IP3R and TRPC3 
nodes in the network.  We 
observe that both proteins 
have oscillatory behavior, 
in agreement with 
experimental data [39].  
Interestingly, these 
proteins display different 
oscillatory patterns in 
terms of their time-steps.  
As a control, we knocked-
out the IP3R from the 
bionetwork and observe 
that the IP3R has no 
activity; interestingly, 
TRPC3 is still oscillatory, 
but has an altered pattern 
of oscillations (Figure 4B).  
This may be expected as 
CWild Type (WT) Synchronous B IP3R KO Wild Type (WT) Asynchronous
Gβ3 KO
A
E
AND ?? OR Rewiring
Figure 4: Boolean Modeling Predicts Wild-Type (WT) and Knock Out (KO) 
phenotypes
(A) Plots of Boolean state vs. Time steps from synchronous modeling recapitulate 
the oscillatory pattern of IP3R and TRPC3 in Wild Type cells. Both the channels 
show a distinct oscillatory pattern with fixed time periods. (B) Boolean modeling with 
IP3R node knocked out (Control) shows that IP3R Boolean state remains fixed at 0 
(Off) and TRPC3 oscillatory pattern changes predicting a reduced Ca2+ entry. (C)
Asynchronous update method replicates the oscillatory pattern of IP3R and TRPC3 
but random update of nodes leads to varying time periods. (D) Rewiring of AND & 
OR in logical rules fails to provide oscillations in the model. (E) Boolean modeling of 
Ca2+ network after knocking out Gβ3 node show no change in oscillatory pattern of 
IP3R and TRPC3 Boolean states as compared to Wild Type (WT)
CWild Type (WT) Synchronous B IP3R KO Wild Type (WT) Asynchronous
Gβ3 KO
A
E
TRPC3 can be activated in an IP3R-
independent manner, although this 
has often been described in over-
expression experiments [5].  In our 
asynchronous model (Figure 4C), we 
still observe an oscillatory pattern, 
although both IP3R and TRPC3 
oscillatory patterns no longer exhibit 
a fixed time period.  This 
demonstrates that this network is 
robust in generating oscillatory 
patterns. Moreover, since we are 
trying to find a correlation between 
change in oscillatory time periods 
and change in cellular Ca2+ levels, 
asynchronous Boolean modeling 
poses a major limitation.  Specifically, 
asynchronous modeling alters the 
rate at which nodes are updated; 
thus, the time-periods measurements 
between oscillations would be 
corrupted.  In order to characterize 
the oscillations of the system we 
need a non-random model; therefore, 
for the purposes of this manuscript 
we chose to explore synchronous 
models.  Importantly, in control 
experiments, we randomized the 
Boolean rules for all nodes by 
changing all ANDs to OR and vice 
versa, and observe no oscillatory 
patterns in our synchronous models 
(Figure 4D).  This data confirms the 
oscillatory patterns observed under 
both synchronous and asynchronous 
simulations are not random in nature. 
Experimental Validation of Network Simulations 
 To determine whether our synchronous models are informative, we knocked-out all of the 
nodes in the network one at a time and recorded the results (Table 2).  Several of these simulations 
are corroborated by experimental literature.  For example, simulated deletion of Homer results in 
increased Ca2+ entry through TRPC3 without altering Ca2+ release through IP3Rs, as is observed 
experimentally [40;41].  Another example is IRBIT, which is an inhibitor of the IP3R.  Its absence in 
the network predicts increased Ca2+ release and entry, in accord with the studies of Ando et al 
[42;43].  Knock-out of PKC from our network predicts that Ca2+ release is abolished, while Ca2+ entry 
is substantially enhanced.  Indeed, the work of Venkatachalam et al. clearly demonstrates that 
pharmacological inhibition of PKC validates our prediction [5].   
Table 2: Knock out Phenotypes Predicted by Boolean Modeling and Literature 
Predictions 
 
Oscillation Pattern Knock 
Out 
Node(s) 
IP3R TRPC3 
Predicted Phenotype References 
DANGER 1(ON)-6(OFF) 3(ON)-4(OFF) IP3R remain open for shorter 
interval and TRPC3 oscillation 
change to single type 
oscillations 
Experimentally 
validated 
IP3R 0 3(ON)-3(OFF) Calcium release stops and TRP 
channels show only DAG 
mediated/Basal oscillations. 
[1;3;5;63] 
GΒ3 2(ON)-6(OFF) 3(ON)-3(OFF)-
1(ON)-1(OFF) 
No change as compared to wild 
type 
Experimentally 
validated 
CamKII 3(ON)-5(OFF) 5(ON)-3(OFF) Calcium release and entry both 
increase as channel remain 
open for longer time and 
closing time decreases. 
 
PKC 0 1 Calcium release goes off 
completely and TRP channels 
remain constantly ‘ON’ 
[5;64] 
ATPcyt 3(ON)-6(OFF) 3(OFF)-3(ON)-
1(OFF)-2(ON) 
Calcium release increases, as 
IP3R remain open for longer 
times.  TRPC also remain open 
longer as compared to wild 
type. 
[65;66] 
CaBP1 2(ON)-6(OFF) 3(ON)-3(OFF)-
1(ON)-1(OFF) 
No change as compared to wild 
type 
[67] 
IP3 0 3(ON)-3(OFF) Same as IP3R KO [68] 
SERCA 3(ON)-6(OFF) 3(OFF)-3(ON)-
1(OFF)-2(ON) 
Similar to ATP-vicinity KO  
DAG 4(ON)-6(OFF) 2(ON)-8(OFF) Calcium release affected, as 
channels remain open for 
longer time but there is no high 
concentration release. Entry 
decreases, as TRPC remains 
closed for longer times. 
[5;64] 
PKA, 
cAMP 
2(ON)-6(OFF) 3(ON)-3(OFF)-
1(ON)-1(OFF) 
Calcium release decreases as 
channel remain open for same 
time as wild type but no high 
concentration release events. 
Entry remains normal. 
[69-71] 
Ligand, 
Receptor, 
PLC G, 
PLC B 
0 0 No oscillations in network as it 
remains all ‘OFF’ 
[28;72-77] 
IRBIT 3(ON)-5(OFF) 5(ON)-3(OFF) Release and entry both 
increase 
[42;43] 
Calmodulin 3(ON)-4(OFF) 3(ON)-4(OFF) Release increases but entry 
decreases 
[78-80] 
HOMER 2(ON)-6(OFF) 5(ON)-3(OFF) Release remains unaffected 
while calcium entry increases 
[41] 
 
Network simulations with Gβ3 knocked-out from the network, exhibit no change in calcium 
mobilization (Figure 4E). Based on in vitro data, one might predict that removal of Gβ3 from the 
network would result in a decrease in Ca2+ release. Although, our Boolean update rule for Gβ3 was 
based on in vitro data, but when taken together with essentiality information, which was derived from 
differential and compensatory cellular expression, the rule recapitulates the in vivo phenotype (Figure 
3e).  
 
Experimental Validation of Network Predictions 
DANGER1a 
  To extend on these findings, we examined the role of DANGER1a; a member of the newly-
discovered DANGER developmental superfamily [44].  This protein was discovered through a yeast-
2-hybrid screen with the IP3R, and was demonstrated to regulate IP3R activity and neuronal 
development [44;45].  Specifically, DANGER1a decreases the open-probability of the IP3R at high 
Ca2+-concentrations (>300 nM).  This in vitro data was used to construct the Boolean rules for 
DANGER1a. Specifically, we defined two different activation states for IP3R release, HIGH and LOW. 
Under HIGH release conditions, 
DANGER1a acts as an inhibitor to 
IP3R activity, while, under LOW 
release conditions, it plays a non-
essential, non-inhibitory role. As 
DANGER1a is inhibitor in our in vitro 
analyses, one would expect that 
knock-out of DANGER1a would result 
in increased Ca2+ release.  However, 
as shown in Figure 5a, our dynamic 
model predicts that knock-out of 
DANGER1a would result in an overall 
decrease of Ca2+ mobilization.   
 
To reconcile these results we 
turned to DANGER1a knock-out mice.  
Shown in Figure 5b, the Cre/Flox 
DANGER1a knock-out mouse was 
properly constructed as shown by 
southern analysis and PCR (Figure 5b, 
see Methods for complete description).  
From embryonic mice, we cultured 
primary spinal cord neurons and 
measured intracellular Ca2+ transients 
in response to serotonin, using the 
fluorescent Ca2+ indicator, Fura-2AM 
(see Methods).  These experiments 
reveal that spinal cord neurons from 
mice, either heterozygous or 
homozygous for DANGER1a knock-
out, have a decrease in overall Ca2+ 
WT HE T KOKO
0
20
40
60
80
100
WT
n=45
HE T
n=37
KO
n=51
p<  0.01
ANOVA
p=0.000
1
p<  0.01
10 d culture
spinal cord 
neurons
C
a2
+
m
ob
ili
za
tio
n 
10
 μM
5‐
H
T
(A
.U
., 
ar
ea
 u
nd
er
 c
ur
ve
)
C
a2
+
m
ob
ili
za
tio
n 
10
 μM
5‐
H
T
(A
.U
., 
ar
ea
 u
nd
er
 c
ur
ve
)
0 105 210 315 420
1.0
1.5
2.0
T ime (sec)
R
at
io
 (
34
0 
/3
80
 n
m
)
10 μM
5‐HT WT
HE T
KO
b
c d
DANGER KO
Figure 5: Boolean Modeling accurately predicts in vivo DANGER KO 
phenotype. (a) Boolean Modeling of our network with DANGER1a node knocked 
out predicts that an altered oscillatory pattern and a reduced Ca2+ mobilization. (b)
(top) Southern analysis of embryonic stem cells generated by Ozgene©.  Cells from 
lane A57 were used to make DANGER1A mice. (bottom) PCR analysis for 
DANGER1a transcript in Wild Type (WT), Heterozygous (HET) and DANGER1a 
knock out (KO) mice. (c) Quantification of Ca2+ mobilization in spinal cord neurons 
from WT, HET and DANGER1a KO mice stimulated with 1 mM serotonin (% of WT, 
area under curve, n = total number of cells from 3 independent experiments, Error 
bars: Std dev) (d) Representative calcium traces from one complete imaging 
experiment. 
a
mobilization when stimulated with serotonin (Figure 5c).  Surprisingly, these results recapitulate the 
predictions from our Boolean model, not the intuitive expectations that could be projected from the in 
vitro data alone.   
 
Discussion  
In this study, we successfully used qualitative data from various experimental studies to 
develop a Boolean dynamic model for the PLC-coupled Ca2+ signaling pathway.  A number of 
implications can be derived from this work: (i) descriptive and predictive models can be built in the 
absence of kinetic data for multiple receptors (muscarinic, serotonergic, B-cell receptor), (ii) these 
models can be used to predict mutant/knock-out phenotypes which can be validated experimentally, 
and (iii) in some cases, these models can be used to anticipate non-intuitive biological effects.  From 
these preliminary studies, we propose that refining Boolean models of Ca2+ signaling will likely 
provide a rich resource for experimental biologists. 
 
 By gathering and organizing current knowledge about PLC-coupled Ca2+ signaling into a 
bionetwork, the biological information is organized into local structures.  This allows the interactions 
between components of the pathway to become more accessible and easier to understand.  Indeed, 
network topology can identify the various feedback and feed-forward loops, as well as the most 
connected nodes (i.e. hubs) in the system. Feedback and feed-forward loops represent the regulatory 
control in the signaling pathway, while hubs signify the most regulated components in the network.  In 
our bionetwork, both the IP3R and TRPC3 emerge as hubs.  This is not surprising as both IP3R and 
TRPC3 are heavily regulated calcium channels [1;4;46].  We also observe that our simulations accord 
with many observations from the literature (Table 2).  Importantly, our bionetwork also approximates 
the oscillatory behavior observed during cellular Ca2+ signaling, as well as the experimental results 
obtained for Gβ3 and DANGER1a in serotonin-induced signaling pathways (Fig 4 and 5).  Although 
similar types of results have been obtained from differential equation based models of calcium 
signaling [17;18], we propose that Boolean modeling represents an independent and powerful tool for 
examining signaling pathways when detailed kinetic data does not exist.  Due to the need for 
extensive computational power, kinetic models are often not feasible; thus Boolean bionetwork 
modeling has great potential for measuring Ca2+ signaling pathways that lack kinetic data.   
  
Of particular interest is the observation that our Boolean model creates oscillatory patterns for 
both IP3R and TRPC3 channel opening in wild type and various mutant/knock-out conditions (Fig 4a-
c,e). This oscillatory pattern is not random and/or an artifact of our approach; when the logical rules 
for ‘AND’/‘OR’ are rewired, the network fails to generate any oscillations (Fig 4d). The accuracy of our 
network is further evident from comparisons with experimental results. Changes in oscillatory 
frequency of calcium channel activity observed in our Boolean analysis correlate with experimental 
measurements for changes in Ca2+ mobilization in various mutant/knock-out cell types (Fig 3-5 and 
Table 2). The ability of this bionetwork to consistently replicate WT and mutant phenotypes suggests 
that the data used to construct the rules is accurate and that general trends in Ca2+ mobilization can 
be modeled.   
 
 Another interesting finding is that in some cases when in vitro and in vivo results conflict, 
Boolean modeling can predict results for the in vivo phenotype using in vitro rules. In our study, 
network modeling predicted phenotypes that were counter-intuitive to in vitro results for DANGER1a. 
However, biochemical experiments are consistent with the predicted network phenotype. The ability 
of networks to predict counter-intuitive in vivo phenotypes for mutant/knock-out cells may not always 
hold true, as we have observed it only for one node in our network. Nevertheless, this idea has 
appeal. It is not unprecedented that biochemical interactions under cellular conditions, and in 
presence of other interacting biochemical components can behave differently from in vitro 
interactions. Given this, modeling studies should also use a holistic approach, and study cell as a 
system and not just as reductionist version of individual interactions.   Our network illustrates that this 
systems biological perspective for studying cells as a network of cross-interacting biological reactions, 
rather than as individual interactions, may provide a more accurate depiction of cellular processes. 
 
 To date, Boolean analysis has been utilized to study gene regulation patterns[47-49], Abscisic 
acid signaling pathway [29], immune responses[50], cholesterol biosynthesis [51], and survival 
signaling in T-cells[52].   Taken together with our analysis, we theorize that Boolean network can be 
used to study any biological pathways, providing clues for further experimental work. After 
experimental verification, this new information can feed back into the network, thereby improving the 
model.  
 
A limiting factor to the Boolean modeling approach is that it depends on information obtained 
from different sources. Thus, the quality and accuracy of information used to define logical rules can 
significantly impact the network results. Likewise bionetworks can be incomplete, as in the case of 
this study. There are many other calcium networks described (but not modeled) which are bigger and 
more complex (e.g. Berridge model [53]), but in this paper we have focused only on a smaller network 
that forms backbone of all GPCR and RTK calcium networks.  However, novel nodes and edges will 
be added in future, as our understanding of these pathways gets better. It is hard to say how much of 
the results obtained from this study might change after addition of novel nodes and edges in the 
future.  Nonetheless, these experimental data can be used to iteratively define the rules for our 
Boolean modeling, with the resulting predictions paving the way for further experimental research.   
 
The network presented here can be accessed online, and codes for creating Boolean network 
models are available at BooleanNet (http://code.google.com/p/booleannet/).  We encourage the Ca2+-
signaling community to provide additional rules, which have been experimentally validated, to be 
incorporated into these networks.   Currently, our bionetwork is very specific; however, the modular 
nature of Boolean networks makes it very easy to modify and/or increase the network complexity.  
Thus, we envision that development of this resource will likely lead to the construction of cell-specific 
Ca2+ signaling networks.  Further, we believe that this wiki approach will allow for an accurate and 
detailed expansion of the Ca2+ signaling network, which in turn will improve its predictive power. 
 
In congress with two companion studies (Hong et al, Ko et al, Physics Archives 2009), we 
theorize that phylogenetic profiles can be used to improve network connectivity.  Indeed, phylogenetic 
profiles are robust in predicting protein functionality, even in highly divergent sequences.  As these 
predictions of functionality can be encoded into Boolean operators, it stands to reason that this 
information would improve the predictive performance of the network.  Further, other predictions that 
can be obtained from phylogenetic profiles, such as protein-protein interactions, can also aid in 
creating additional edges between nodes.  It is reasonable to consider that networks incorporating 
this data may also be useful in identifying rogue predictions from our phylogenetic profiles.  For 
instance, if protein A is predicted to be a kinase that phosphorylates protein B, but by incorporating 
this rule the network no longer adheres to the known relationships, it calls into question the validity of 
the phylogenetic profile prediction.  This is an attractive iterative process as Boolean networks are 
computationally inexpensive.  To what extent this and other types of predictive computational biology 
can be incorporated into Boolean networks, and their efficacy, is an exciting realm for exploration. 
 
  In the future, our work will also focus on developing a more complex model by including nodes 
and connections already described in Berridge model [54] and by including other phenotypic 
characteristics into the bionetwork. For example, DANGER1a, TRPCs, and IP3R are also involved in 
neural growth [4;44;55-57].  Therefore, a neuronal development network can be integrated into the 
Ca2+ signaling network.  In theory, this should allow for the simultaneous decoding of these two highly 
interconnected networks. Since calcium mobilization is not an ON/OFF process, we will also explore 
higher order discrete modeling approaches towards better simulations. We will also test hybrids of 
discrete/continuous models to better understand calcium mobilization; particularly in cases where 
some kinetic data is available.  In addition to modeling signaling pathways, these networks can aid in 
the identification of drug targets based on network connectivity (i.e. some nodes serve as better drug 
targets than others [58;59]).  We propose that in the long-term, our refined Boolean modeling may 
lead to increased capacity to create predictive stage models likely to identify targets for therapeutic 
intervention.   
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Materials and Methods 
Bionetwork and Boolean Modeling 
Nodes and edges in bionetwork were chosen after a comprehensive literature search for components 
that are part of Serotonin Ca2+ pathway and/or are known to interact with any of the other 
components of the network. Some of the interactions are very well established based on experimental 
data but in cases where conflicting results existed, nodes and edges were defined based on 
relevance and accuracy of experimental support provided in literature. Further, only nodes that have 
causal effects on the system were included. Associative interactions, where directionality information 
was not present in current literature could not be included.  For a list of references used in generating 
the network, see Supplemental References.  
 
The model in Figure 1 was drawn with yED graph editor (http://www.yworks.com/en/index.html). The 
Boolean modeling was performed with a custom Python script (http://www.python.org). Update rules 
for each node were defined based on legacy knowledge and experimental data obtained prior to this 
modeling.(Table1). For synchronous modeling, all the nodes were updated for their respective rules 
at all the time steps. For asynchronous modeling, random numbers of nodes were updated at each 
time step. A random update order was selected at each step from N! possible permutations (N = no. 
of nodes). As shown in Chaves et al and Li et al [29;60],  this method provides a random differential 
time to each reaction/interaction event. Boolean states of each node at each step (for 50 time steps in 
case of synchronous) were recorded and analyzed for repeating patterns (Attracting behavior).  
 
For random rewiring of AND and OR in logical rules, all the ANDs in the logical rules were changed to 
OR and vice versa. Synchronous update method was used after rewiring to get an equivalent of 
randomization in this network study.  
 
Calcium Imaging- Calcium imaging was performed as previously described [61].  Briefly neurons 
were loaded with 1mM Fura-2-AM for 5 minutes.  B-cells were loaded with 2mM Fura-2-AM for 25 
minutes.  Neuronal experiments were conducted at 370C and Kreb’s solution was supplemented with 
2mM CaCl2 and 1mM glycine.  B-cell experiments were conducted at room temperature as previously 
described [32].  HEK-293 and A7r5 cells were imaged exactly as in Patterson et al [32]. 
 
Cell Culture- Cells were cultured using the protocol from Alldred et al [62] . Briefly, spinal cord 
neurons were generated from DANGER1A deficient embryonic day 14.5 embryos generated by 
crossing of DANGER1A+/- mice on a 129SvJ inbred background.  Spinal cords were collected in PBS 
containing 5.5 mM glucose and treated with papain (0.5 mg/ml) and DNase I (10 µg/ml) (both from 
Sigma, St. Louis, MO) in PBS containing 1 mg/ml bovine serum albumin (Fraction V, Sigma) and 10 
mM glucose for 15 min at room temperature. The cells were triturated with a fire-polished Pasteur 
pipette and plated on poly-L-lysine-coated glass coverslips (22 x 22 mm) at 4 x 104 cells per square 
centimeter in modified Eagle medium (MEM) (Invitrogen) containing 10% v/v fetal bovine serum (FBS) 
(Invitrogen) in an atmosphere of 10% CO2. After 60 min, the medium was replaced with fresh MEM 
containing 10% v/v FBS. The genotype of cultures was determined using PCR as follows. Tail 
biopsies (3 mm) were incubated for 30 min at 55°C in 25 µl lysis buffer (200 mM NaCl, 5 mM EDTA, 
0.2% SDS, 100 mM Tris-HCl, pH 8.5), and 1% of the supernatant was used for PCR using standard 
conditions with the primer 5'-ACAGAACCAATCGGTGTG-3' combined with either 5'-
CTCGTTCTCGGGAATCGT-3' to amplify the wild-type DANGER1A locus or the primer 5'-
GCGCTTCCAAGGCTGTGAA-3' to amplify the mutant DANGER1A locus. The 24-hr-old cultures that 
exhibited the desired genotypes were turned upside down onto a glial feeder layer in a Petri dish 
containing Neurobasal-A supplemented with B27 (Invitrogen), in an atmosphere of 10% CO2. Feeder 
cells were prepared from cortices of newborn rat pups as described (Banker and Goslin, 1998 ). 
Neuron cultures were maintained without medium change for 18 d in vitro (DIV) and then transferred 
into new Petri dishes containing Neurobasal A/B27 supplemented with 1 µM 6-cyano-7-
nitroquinoxaline-2,3-dione (CNQX) and 100 µM 2-amino-5-phosphonovaleric acid (Sigma), with the 
cells facing up. Neurons were processed for calcium imaging at 10 DIV. 
 
Microsomal Assays- Microsomal assays were performed as previously described [63;64].   
In vitro Binding assays – In vitro assays were performed exactly as previously described [63;65]  
 
Yeast-2-Hybrid Assays – Yeast-2-Hybrid assays were performed exactly as previously described  
[63;65].  
 
Materials- Anti-myc antibody, 5-HT, Anti-human IgM, carbachol, and all buffer components were 
obtained from Sigma-Aldrich (St. Louis, MO).  Yeast-2-Hybrid reagents were obtained from 
CLONETECH (Palo Alto, CA).  All cell culture reagents and Fura-2-AM were obtained from 
Invitrogen. 3IP3 and 45Ca2+ were obtained from Amersham Biosciences.  DANGER1a knock-out mice 
were generated by Ozgene© (Australia).   
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